Assenagon Asset Management S.A. Grows Position in Mettler-Toledo International Inc. (NYSE:MTD)

Assenagon Asset Management S.A. increased its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 45.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 32,330 shares of the medical instruments supplier's stock after purchasing an additional 10,170 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.15% of Mettler-Toledo International worth $48,485,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Family Firm Inc. purchased a new stake in Mettler-Toledo International during the second quarter worth approximately $25,000. Blue Trust Inc. lifted its stake in Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock valued at $34,000 after buying an additional 17 shares during the last quarter. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International in the second quarter valued at approximately $42,000. Itau Unibanco Holding S.A. purchased a new stake in Mettler-Toledo International in the second quarter valued at approximately $42,000. Finally, Crewe Advisors LLC lifted its stake in Mettler-Toledo International by 244.4% in the second quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier's stock valued at $43,000 after buying an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Wall Street Analysts Forecast Growth

MTD has been the subject of several analyst reports. The Goldman Sachs Group upped their price target on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 9th. Stifel Nicolaus upped their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a "buy" rating in a research note on Monday, August 5th. JPMorgan Chase & Co. upped their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research note on Monday, August 5th. Wells Fargo & Company began coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an "equal weight" rating and a $1,400.00 price target for the company. Finally, StockNews.com raised Mettler-Toledo International from a "hold" rating to a "buy" rating in a report on Thursday, July 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $1,363.75.

Mettler-Toledo International Stock Down 0.0 %

MTD stock traded down $0.61 on Friday, reaching $1,292.77. 91,366 shares of the company's stock were exchanged, compared to its average volume of 132,769. The firm has a market cap of $27.43 billion, a PE ratio of 35.58, a P/E/G ratio of 3.95 and a beta of 1.14. Mettler-Toledo International Inc. has a twelve month low of $928.49 and a twelve month high of $1,546.93. The stock has a fifty day moving average of $1,418.52 and a 200-day moving average of $1,393.87.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share for the quarter, beating the consensus estimate of $9.00 by $0.65. The company had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. Mettler-Toledo International's revenue was down 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $10.19 earnings per share. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 40.34 EPS for the current fiscal year.

Insider Activity

In other news, CFO Shawn Vadala sold 250 shares of the company's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CFO Shawn Vadala sold 250 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at approximately $6,884,514. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Christian Magloth sold 1,000 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now owns 734 shares in the company, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.